PUBLISHER: Grand View Research | PRODUCT CODE: 2152250
PUBLISHER: Grand View Research | PRODUCT CODE: 2152250
The global retinal detachment treatment market size was valued at USD 166.1 million in 2025 and is projected to grow from USD 171.4 million in 2026 to USD 214.7 million by 2033, at a CAGR of 3.3% from 2026 to 2033. Europe dominated the market, accounting for the revenue share of 42.6% in 2025. The growth is supported by the continuing clinical burden of rhegmatogenous retinal detachment (RRD), an acute sight-threatening condition that requires timely diagnosis and treatment to prevent permanent vision loss.
RRD is the most common form of retinal detachment and is associated with factors such as increasing age, myopia, previous ocular surgery, and ocular trauma. The market encompasses a range of surgical procedures and supporting technologies used to restore retinal attachment and preserve vision in patients with retinal detachment. Treatment selection depends on the type, location, and extent of detachment and may include PPV, scleral buckling, pneumatic retinopexy, and combined procedures. These approaches require a combination of specialized instruments and visualization technologies to allow surgeons to identify retinal breaks, remove vitreous traction, drain subretinal fluid, apply laser photocoagulation, and introduce intraocular tamponade when required.
Light guides are an important illumination component used during vitreoretinal surgery, particularly pars plana vitrectomy, performed to repair retinal detachment. These fiber-optic devices deliver light inside the eye, allowing surgeons to clearly visualize the retina, vitreous, retinal tears, and other structures during surgery. Depending on the procedure, light guides can provide focused, widefield, or midfield illumination. The availability of different gauge sizes, including 20G, 23G, 25G, 27G, and smaller sizes, supports their use in various minimally invasive retinal procedures. Bausch + Lomb, for example, offers multiple endoillumination options and fiber-optic accessories for retinal detachment procedures.
The growing adoption of minimally invasive vitrectomy is a major factor supporting demand for light guides. As retinal surgeons increasingly use small-gauge instruments, illumination systems must provide sufficient light through smaller surgical access points without compromising visualization. Recent clinical guidance also emphasizes that appropriate illumination is critical during retinal detachment surgery.
Population aging is a major driver of demand for retinal detachment treatment. According to Eurostat, people aged 65 years and older accounted for 22.0% of the EU population in 2025, up from 21.6% in 2024. Retinal detachment is particularly relevant in older adults because the incidence of RRD tends to peak in the sixth and seventh decades of life, often in association with age-related posterior vitreous detachment. The expanding older population, therefore, increases the number of individuals who require retinal examinations, diagnoses, and treatment for retinal tears and detachments. The increasing volume of cataract surgeries is expected to further support demand for retinal detachment treatment across Europe.
Global Retinal Detachment Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global retinal detachment treatment market report based on product, treatment, disease, age group, end use, and region: